Works by Sonis, Stephen T.

Results: 72
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group.

    Published in:
    1999
    By:
    • Sonis, Stephen T.;
    • Eilers, June P.;
    • Epstein, Joel B.;
    • LeVeque, Francis G.;
    • Liggett, William H.;
    • Mulagha, Mary T.;
    • Peterson, Douglas E.;
    • Rose, Ann H.;
    • Schubert, Mark M.;
    • Spijkervet, Frederik K.;
    • Wittes, Janet P.;
    • Sonis, S T;
    • Eilers, J P;
    • Epstein, J B;
    • LeVeque, F G;
    • Liggett, W H Jr;
    • Mulagha, M T;
    • Peterson, D E;
    • Rose, A H;
    • Schubert, M M
    Publication type:
    journal article
    25
    26
    27
    28

    The pathobiology of mucositis.

    Published in:
    Nature Reviews Cancer, 2004, v. 4, n. 4, p. 277, doi. 10.1038/nrc1318
    By:
    • Sonis, Stephen T.
    Publication type:
    Article
    29
    30
    31

    Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck.

    Published in:
    2014
    By:
    • Allison, Ron R;
    • Ambrad, Aaron A;
    • Arshoun, Youssef;
    • Carmel, Richard J;
    • Ciuba, Doug F;
    • Feldman, Elizabeth;
    • Finkelstein, Steven E;
    • Gandhavadi, Ranjini;
    • Heron, Dwight E;
    • Lane, Steven C;
    • Longo, John M;
    • Meakin, Charles;
    • Papadopoulos, Dimitrios;
    • Pruitt, David E;
    • Steinbrenner, Lynn M;
    • Taylor, Michael A;
    • Wisbeck, William M;
    • Yuh, Grace E;
    • Nowotnik, David P;
    • Sonis, Stephen T
    Publication type:
    journal article
    32
    33

    Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 9, p. 1433, doi. 10.1002/cncr.28553
    By:
    • Allison, Ron R.;
    • Ambrad, Aaron A.;
    • Arshoun, Youssef;
    • Carmel, Richard J.;
    • Ciuba, Doug F.;
    • Feldman, Elizabeth;
    • Finkelstein, Steven E.;
    • Gandhavadi, Ranjini;
    • Heron, Dwight E.;
    • Lane, Steven C.;
    • Longo, John M.;
    • Meakin, Charles;
    • Papadopoulos, Dimitrios;
    • Pruitt, David E.;
    • Steinbrenner, Lynn M.;
    • Taylor, Michael A.;
    • Wisbeck, William M.;
    • Yuh, Grace E.;
    • Nowotnik, David P.;
    • Sonis, Stephen T.
    Publication type:
    Article
    34

    Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 24, p. 4268, doi. 10.1002/cncr.28365
    By:
    • Limaye, Sewanti Atul;
    • Haddad, Robert I.;
    • Cilli, Fiona;
    • Sonis, Stephen T.;
    • Colevas, A. Dimitrios;
    • Brennan, Michael T.;
    • Hu, Kenneth S.;
    • Murphy, Barbara A.
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50